Healthcare provider profile · identity verified

Veronika White

Internal Medicine · WEST VIEW, PA · NPI 1306135819

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	324	75
Atorvastatin Calcium	Atorvastatin Calcium	294	81
Levothyroxine Sodium	Levothyroxine Sodium	286	64
Lisinopril	Lisinopril	250	62
Pravastatin Sodium	Pravastatin Sodium	216	54
Losartan Potassium	Losartan Potassium	211	54
Gabapentin	Gabapentin	205	37
Omeprazole	Omeprazole	197	42
Metformin Hcl	Metformin Hcl	160	43
Pantoprazole Sodium	Pantoprazole Sodium	158	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	138	24
Hydrochlorothiazide	Hydrochlorothiazide	132	35
Metoprolol Succinate	Metoprolol Succinate	129	27
Albuterol Sulfate Hfa	Albuterol Sulfate	128	47
Glimepiride	Glimepiride	109	25
Trazodone Hcl	Trazodone Hcl	108	25
Simvastatin	Simvastatin	106	26
Sertraline Hcl	Sertraline Hcl	104	28
Lorazepam	Lorazepam	103	20
Oxycodone Hcl	Oxycodone Hcl	98	17
Tamsulosin Hcl	Tamsulosin Hcl	97	25
Clonazepam	Clonazepam	94	14
Metoprolol Tartrate	Metoprolol Tartrate	90	18
Rosuvastatin Calcium	Rosuvastatin Calcium	84	27
Alprazolam	Alprazolam	82	16
Atenolol	Atenolol	70	18
Jardiance	Empagliflozin	69	suppressed
Fluticasone Propionate	Fluticasone Propionate	68	22
Eliquis	Apixaban	65	14
Ibuprofen	Ibuprofen	65	18
Tramadol Hcl	Tramadol Hcl	63	14
Potassium Chloride	Potassium Chloride	62	16
Alendronate Sodium	Alendronate Sodium	59	18
Famotidine	Famotidine	58	15
Xarelto	Rivaroxaban	58	suppressed
Furosemide	Furosemide	54	15
Zolpidem Tartrate	Zolpidem Tartrate	54	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	20
Meloxicam	Meloxicam	50	13
Carvedilol	Carvedilol	48	12
Hydralazine Hcl	Hydralazine Hcl	47	suppressed
Metformin Hcl Er	Metformin Hcl	44	12
Fluoxetine Hcl	Fluoxetine Hcl	43	suppressed
Valsartan	Valsartan	43	12
Bupropion Hcl Sr	Bupropion Hcl	40	suppressed
Duloxetine Hcl	Duloxetine Hcl	40	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	40	11
Ondansetron Odt	Ondansetron	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	11
Allopurinol	Allopurinol	34	suppressed
Propranolol Hcl	Propranolol Hcl	34	suppressed
Azithromycin	Azithromycin	33	28
Nystatin	Nystatin	33	suppressed
Ozempic	Semaglutide	33	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Baclofen	Baclofen	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Repaglinide	Repaglinide	31	suppressed
Ondansetron Hcl	Ondansetron Hcl	30	12
Buspirone Hcl	Buspirone Hcl	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Methocarbamol	Methocarbamol	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Montelukast Sodium	Montelukast Sodium	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Methylprednisolone	Methylprednisolone	23	19
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	18
Finasteride	Finasteride	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Prednisone	Prednisone	20	14
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Glipizide	Glipizide	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	12
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Ibu	Ibuprofen	13	suppressed
Temazepam	Temazepam	13	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Risperidone	Risperidone	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Sumatriptan	Sumatriptan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error